Nivolumab in salivary gland cancers: confronting the challenges of unlocking the therapeutic benefits of immunotherapy for rare diseases

• Antoine Desilets,
• Alan L Ho

Affiliations

Antoine Desilets

Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA

Alan L Ho

Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA